An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Lantheus Holdings, Inc. will host a conference call and webcast on May 2, 2024, at 8:00 a.m. Eastern Time to discuss its first quarter 2024 financial and operating results.
Lantheus Holdings, Inc. organizzerà una teleconferenza e un webcast il 2 maggio 2024, alle 8:00 del mattino, ora dell'Est, per discutere i risultati finanziari e operativi del primo trimestre del 2024.
Lantheus Holdings, Inc. llevará a cabo una llamada de conferencia y transmisión web el 2 de mayo de 2024, a las 8:00 a.m. hora del Este, para discutir los resultados financieros y operativos del primer trimestre de 2024.
랜디어스 홀딩스, Inc.는 2024년 5월 2일 오전 8시(동부 표준시)에 2024년도 1분기 재무 및 운영 결과에 대해 논의하기 위한 컨퍼런스 콜 및 웹캐스트를 주최할 예정입니다.
Lantheus Holdings, Inc. organisera une conférence téléphonique et une webdiffusion le 2 mai 2024, à 8h00, heure de l'Est, pour discuter des résultats financiers et opérationnels du premier trimestre de 2024.
Lantheus Holdings, Inc. wird am 2. Mai 2024 um 8:00 Uhr Eastern Time eine Telefonkonferenz und ein Webcast veranstalten, um die finanziellen und betrieblichen Ergebnisse des ersten Quartals 2024 zu besprechen.
Positive
None.
Negative
None.
BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, May 2, 2024, to discuss its financial and operating results for the first quarter of 2024.
To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.
Contacts:
Mark Kinarney Vice President, Investor Relations 978-671-8842 ir@lantheus.com
lantheus holdings, inc. (nasdaq: lnth) is the parent company of lantheus medical imaging, inc. (lmi), which is a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. lmi provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. lmi’s key products include the echocardiography contrast agent definity® vial for (perflutren lipid microsphere) injectable suspension; technelite® (technetium tc99m generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and xenon (xenon xe 133 gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs. the company is headquartered in north billerica, massachusetts with offices in puerto rico and canada. for more information, visit www.lantheus.com.
